FDA approves a more ‘personalized’ cancer drug

Cancer treatments are becoming more personal. The Food and Drug Administration recently gave accelerated approval for Keytruda, a pre-existing drug from Merck, for use on patients diagnosed with solid tumors containing a specific biomarker. Rather th...

Is This How We will Cure Cancer?


For 85% of kids with a terrible cancer called acute lymphoblastic leukemia, chemotherapy is a cure–but not for Emily Whitehead. Diagnosed at 5, she suffered an infection from her first round of chemo...

Researchers develop femtosecond laser that can diagnose, blast cancerous tumors

Researchers develop femtosecond laser that can diagnose, blast cancerous tumors

Researchers at the University of Tennessee's Center for Laser Applications have developed a femtosecond laser that can non-invasively diagnose, map, irradiate and burn cancerous tumors. Utilizing a beam that pulses at one-quadrillionth of a second, the technology is able to seek out growths and obliterate them with an increased burst of intensity. "Using ultra-short light pulses gives us the ability to focus in a well confined region and the ability for intense radiation," says Associate Professor of Physics Christian Parigger. "This allows us to come in and leave a specific area quickly so we can diagnose and attack tumorous cells fast." The swift, precise technique can avoiding heating up adjacent, healthy tissues and has potential for use in outpatient procedures, particularly for people afflicted with brain tumors. For now, however, the scientists are working with the non-profit University of Tennessee Research Foundation to bring their tech to market. Roll past the jump for the press release and a glimpse of the laser in action.

Continue reading Researchers develop femtosecond laser that can diagnose, blast cancerous tumors

Filed under:

Researchers develop femtosecond laser that can diagnose, blast cancerous tumors originally appeared on Engadget on Tue, 24 Jul 2012 05:13:00 EDT. Please see our terms for use of feeds.

Permalink   |   | Email this | Comments